- U.S. consumer groups oppose Teva bid for generic drug rival Mylan (reuters.com)
proposed merger of the two largest U.S. generic drug makers drew fire....from Consumers Union...asked antitrust enforcers to stop Teva Pharmaceutical Industries Ltd's proposal to purchase Mylan saying it would lead to higher prices and more drug shortages.
- PhRMA report outlines 420 medicines in neurological pipeline (drugstorenews.com)Medicines in Development for Neurological Disorders (phrma.org)
..biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis and Parkinson’s disease...PhRMA and the Epilepsy Foundation...released a new report...
- Challenges for Health-System Pharmacists (pharmacytimes.com)
Stephen F. Eckel, PharmD, MHA, associate professor at the Eshelman School of Pharmacy at UNC talks about the challenges that health-system pharmacists are currently facing. (video)
- How The Aetna-Humana Deal May Affect CVS Health’s Pharmacy Benefit Management (seekingalpha.com)
Humana is the number six largest PBM with 6% of the market in 2014. That's only a quarter of CVS's 24% market share,...Aetna has a 12-year long-term contract agreement with CVS to operate as Aetna's pharmacy benefit management business, which started in 2010...
- GSK first drugmaker to tie up with new Crick institute (newsdaily.com)
GlaxoSmithKline...collaboration with the Francis Crick Institute,..Named after the Nobel laureate who co-discovered the molecular structure of DNA,...The deal with GSK does not involve any money changing hands but allows teams of scientists...to work side by side on the underlying biology of diseases,...
- Uber Cofounder’s ‘Uber For Healthcare’ Startup Raises $14 Million (forbes.com)
"Uber for healthcare" startup has an advantage....cofounder Oscar Salazar, as Uber’s founding CTO,....Pager tries to take the process further by making your appointment instant and for a flat fee...urgent care visit is $50,...physical is $100 and a phone consultation $25...is focused on delivering a broader range of care options on demand"...
- The top 20 highest-paid biopharma CEOs (fiercepharma.com)
pharma compensation landscape...Sales figures don't matter...The world's biggest drug companies by revenue don't all hand out pay packages of at least $18.6 million, which is the threshold for this year's top-paid CEOs list...Big pay packages don't reflect a company's size.
- Len Schleifer, Regeneron - $41.97 mil
- Jeffrey Leiden, Vertex Pharm. - $36.64 mil
- Brent Saunders, Allergan - $36.61 mil
- Martine Rothblatt, United Therap. - $33.21 mil
- Lamberto Andreotti, BMS - $27.06 mil
- Heather Bresch, Mylan - $25.82 mil
- Kenneth Frazier, Merck - $25.03 mil
- Alex Gorsky, J & J - $24.99 mil
- Robert Hugin, Celgene - $24.24 mil
- Ian Read, Pfizer - $23.28 mil
- Richard Gonzalez, AbbVie - $22.01 mil
- Leonard Bell, Alexion Pharm. - $20.57 mil
- John Martin, Gilead Sciences - $18.96 mil
- Joseph Papa, Perrigo - $18.95 mil
- George Scangos, Biogen - $18.63 mil
- David Pyott, Allergan - $17.79 mil
- Robert Parkinson, Baxter Intern.- $15.30 mil
- John Lechleiter, Eli Lilly - $14.48 mil
- Flemming Ornskov, Shire - $14.22 mil
- Robert Bradway, Amgen - $13.96 mil
- Clinical decision support: no longer just a nice-to-have (healthcareitnews.com)
Value-based reimbursement means quality improvement is now imperative; smart clinical decision support is essential...shift from volume to value finally taking hold, moving toward better clinical care is no longer optional.
- One toke over the line: Race on to develop ‘pot breathalyzer’ (reuters.com)
...the race is on to develop an instant roadside breathalyzer for police to test drivers who may be taking the "high" road...Cannabix Technologies Inc,..expects to be first out of the gate with a "pot breathalyzer" - a handheld device similar to those used to detect alcohol.
- Greece bans export of 25 drugs after pharmacists’ supply warnings (newsdaily.com)
…pharmacists made their warnings – that there had been a significant increase in re-exports of some medicines…"Abuses have been discovered by some players in the pharmaceuticals market,"…ministry would closely check exports and re-exports…file complaints at home and abroad where there is evidence of abuse..